Stock analysis, AI verdict, fundamentals & technical signals
Rating: NEUTRAL
Price: $1.20 Analyst target: $9.00 Upside: 653.14%
NovaBridge Biosciences, a biotech company, focuses on the development of immuno-oncology agents for the treatment of cancer in the United States. The company is headquartered in Rockville, Maryland.
See the full interactive analysis & chart →Informational only — not investment advice.